Alumni raised $1.45B in 2022 - Download Free Report Now

AxoGen (NASDAQ: AXGN)

Off-the-shelf implantable allograft tissue to support peripheral nerve repair and regeneration.

Start Free Trial
Claim Company Profile

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of AxoGen (NASDAQ: AXGN) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About AxoGen (NASDAQ: AXGN)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Companies We Work With

  • 0-Minnetronix.jpg
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.jpg
  • bain.jpg
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • hospira.png
  • jlabs.jpg
  • kimberlyclark.png
  • merck.jpg
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • teleflex.jpg
  • terumo.png
  • zimmerbiomet.png